Antti Tullila

Title: Antti Tullila: Innovator in Polypeptide and Antibody Research

Introduction

Antti Tullila is a notable inventor based in VTT, Finland. He has made significant contributions to the fields of life sciences, particularly in polypeptide analysis and immunodiagnostics. With a total of 2 patents, Tullila's work focuses on innovative methods for screening polypeptides and developing antibodies.

Latest Patents

Tullila's latest patents include methods for screening polypeptides capable of binding specific target molecules. This invention relates to polypeptide analysis and discovery methods, as well as detection methods for target molecules in samples. The invention outlines a method for screening polypeptides that can bind to target molecules and includes a kit for carrying out these methods. Another significant patent involves a recombinant antibody or antigen binding fragment for binding thyroid hormone T4 and halogenated bisphenol A. This patent also covers an isolated nucleic acid molecule that encodes the recombinant antibody, along with methods for producing it and determining T4 levels in samples.

Career Highlights

Antti Tullila has worked with prominent organizations such as Teknologian Tutkimuskeskus VTT Oy and Politecnico di Milano. His experience in these institutions has allowed him to advance his research and contribute to the scientific community.

Collaborations

Some of Tullila's notable coworkers include Tarja Nevanen and Henri Arola. Their collaboration has likely enriched the research environment and fostered innovative ideas in their respective fields.

Conclusion

Antti Tullila's contributions to polypeptide and antibody research highlight his role as an influential inventor in the life sciences sector. His patents reflect a commitment to advancing scientific knowledge and developing practical applications for healthcare.